Latest filing published 22 Jun 2026 for Enliven Therapeutics, Inc., €1.3M.
Insider track record
The Biotech Growth Trust PLC: trading record in brief
All filings by The Biotech Growth Trust PLC on record concern Enliven Therapeutics, Inc. We count 2 filings; the first trade dates from 15 June 2026 and the latest from 22 June 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 22 June 2026, the filings show a transaction worth €1.3M in Enliven Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to The Biotech Growth Trust PLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 31,132 shares@ US$45.960.039% mcap77.0% of flowCommon StockSEC144:0000947871-26-000648
- 10,243 shares@ US$42.360.012% mcap23.0% of flowCommon StockSEC144:0000947871-26-000629
2 of 2 declarations
